Benepali Surge And Imraldi Gains Drive Biogen Biosimilars Past US$500m

 
• By Dean Rudge
  
Car
The US$500m biosimilar sales barrier has been smashed by Biogen, with double-digit growth forecast in 2019 • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products